Systemic levels of lipid peroxidation and its metabolic and dietary correlates in patients with nonalcoholic steatohepatitis

Research output: Contribution to journalArticle

244 Citations (Scopus)

Abstract

BACKGROUND AND AIM: Products of systemic lipid peroxidation are important in the pathogenesis of cardiovascular disease. Subjects with NASH have increased hepatic lipid peroxidation, but it is unknown if they have increased oxidative stress and lipid peroxidation systemically. Therefore, we conducted a study to measure the circulating levels of lipid peroxidation products and their metabolic and nutritional correlates in patients with NASH and controls. METHODS: Systemic lipid peroxidation was assessed by measuring the levels of oxidized LDL (ox-LDL) and thiobarbituric acid-reacting substances (TBARS) in 21 subjects with NASH and 19 controls. Correlations were made between serum lipid peroxidation and nutritional determinants of oxidative stress and defense, serum lipids, insulin resistance, transaminases, and liver histology. The short-term nutrient intake was analyzed by maintaining a 3-wk dietary diary. RESULTS: The serum levels of ox-LDL were significantly higher in NASH patients compared to controls (56 ± 16 U/L vs 40 ± 12 U/L, respectively, p < 0.001). Similarly, serum TBARS were significantly higher in NASH patients compared to controls (3.4 ± 1.3 vs 1.8 ± 0.9 nmols/ml, respectively, p = 0.0001). Insulin resistance was independently associated with ox-LDL (p = 0.01) and TBARS levels (p = 0.01). We found no differences in the intake of various macro- and micronutrients between the two groups and there was no association between nutrient intake and ox-LDL or TBARS. CONCLUSION: Subjects with NASH have significantly higher systemic levels of lipid peroxidation products and this could indicate an increased risk of cardiovascular disease. More studies are needed to evaluate this possibility.

Original languageEnglish
Pages (from-to)1497-1502
Number of pages6
JournalAmerican Journal of Gastroenterology
Volume99
Issue number8
DOIs
StatePublished - Aug 2004

Fingerprint

Lipid Peroxidation
Serum
Insulin Resistance
Oxidative Stress
Cardiovascular Diseases
Food
Micronutrients
Liver
Transaminases
Non-alcoholic Fatty Liver Disease
Histology
Lipids
oxidized low density lipoprotein
thiobarbituric acid

ASJC Scopus subject areas

  • Gastroenterology

Cite this

@article{abca093bcba5442b8988deee61a84b11,
title = "Systemic levels of lipid peroxidation and its metabolic and dietary correlates in patients with nonalcoholic steatohepatitis",
abstract = "BACKGROUND AND AIM: Products of systemic lipid peroxidation are important in the pathogenesis of cardiovascular disease. Subjects with NASH have increased hepatic lipid peroxidation, but it is unknown if they have increased oxidative stress and lipid peroxidation systemically. Therefore, we conducted a study to measure the circulating levels of lipid peroxidation products and their metabolic and nutritional correlates in patients with NASH and controls. METHODS: Systemic lipid peroxidation was assessed by measuring the levels of oxidized LDL (ox-LDL) and thiobarbituric acid-reacting substances (TBARS) in 21 subjects with NASH and 19 controls. Correlations were made between serum lipid peroxidation and nutritional determinants of oxidative stress and defense, serum lipids, insulin resistance, transaminases, and liver histology. The short-term nutrient intake was analyzed by maintaining a 3-wk dietary diary. RESULTS: The serum levels of ox-LDL were significantly higher in NASH patients compared to controls (56 ± 16 U/L vs 40 ± 12 U/L, respectively, p < 0.001). Similarly, serum TBARS were significantly higher in NASH patients compared to controls (3.4 ± 1.3 vs 1.8 ± 0.9 nmols/ml, respectively, p = 0.0001). Insulin resistance was independently associated with ox-LDL (p = 0.01) and TBARS levels (p = 0.01). We found no differences in the intake of various macro- and micronutrients between the two groups and there was no association between nutrient intake and ox-LDL or TBARS. CONCLUSION: Subjects with NASH have significantly higher systemic levels of lipid peroxidation products and this could indicate an increased risk of cardiovascular disease. More studies are needed to evaluate this possibility.",
author = "Naga Chalasani and Deeg, {Mark A.} and David Crabb",
year = "2004",
month = "8",
doi = "10.1111/j.1572-0241.2004.30159.x",
language = "English",
volume = "99",
pages = "1497--1502",
journal = "American Journal of Gastroenterology",
issn = "0002-9270",
publisher = "Nature Publishing Group",
number = "8",

}

TY - JOUR

T1 - Systemic levels of lipid peroxidation and its metabolic and dietary correlates in patients with nonalcoholic steatohepatitis

AU - Chalasani, Naga

AU - Deeg, Mark A.

AU - Crabb, David

PY - 2004/8

Y1 - 2004/8

N2 - BACKGROUND AND AIM: Products of systemic lipid peroxidation are important in the pathogenesis of cardiovascular disease. Subjects with NASH have increased hepatic lipid peroxidation, but it is unknown if they have increased oxidative stress and lipid peroxidation systemically. Therefore, we conducted a study to measure the circulating levels of lipid peroxidation products and their metabolic and nutritional correlates in patients with NASH and controls. METHODS: Systemic lipid peroxidation was assessed by measuring the levels of oxidized LDL (ox-LDL) and thiobarbituric acid-reacting substances (TBARS) in 21 subjects with NASH and 19 controls. Correlations were made between serum lipid peroxidation and nutritional determinants of oxidative stress and defense, serum lipids, insulin resistance, transaminases, and liver histology. The short-term nutrient intake was analyzed by maintaining a 3-wk dietary diary. RESULTS: The serum levels of ox-LDL were significantly higher in NASH patients compared to controls (56 ± 16 U/L vs 40 ± 12 U/L, respectively, p < 0.001). Similarly, serum TBARS were significantly higher in NASH patients compared to controls (3.4 ± 1.3 vs 1.8 ± 0.9 nmols/ml, respectively, p = 0.0001). Insulin resistance was independently associated with ox-LDL (p = 0.01) and TBARS levels (p = 0.01). We found no differences in the intake of various macro- and micronutrients between the two groups and there was no association between nutrient intake and ox-LDL or TBARS. CONCLUSION: Subjects with NASH have significantly higher systemic levels of lipid peroxidation products and this could indicate an increased risk of cardiovascular disease. More studies are needed to evaluate this possibility.

AB - BACKGROUND AND AIM: Products of systemic lipid peroxidation are important in the pathogenesis of cardiovascular disease. Subjects with NASH have increased hepatic lipid peroxidation, but it is unknown if they have increased oxidative stress and lipid peroxidation systemically. Therefore, we conducted a study to measure the circulating levels of lipid peroxidation products and their metabolic and nutritional correlates in patients with NASH and controls. METHODS: Systemic lipid peroxidation was assessed by measuring the levels of oxidized LDL (ox-LDL) and thiobarbituric acid-reacting substances (TBARS) in 21 subjects with NASH and 19 controls. Correlations were made between serum lipid peroxidation and nutritional determinants of oxidative stress and defense, serum lipids, insulin resistance, transaminases, and liver histology. The short-term nutrient intake was analyzed by maintaining a 3-wk dietary diary. RESULTS: The serum levels of ox-LDL were significantly higher in NASH patients compared to controls (56 ± 16 U/L vs 40 ± 12 U/L, respectively, p < 0.001). Similarly, serum TBARS were significantly higher in NASH patients compared to controls (3.4 ± 1.3 vs 1.8 ± 0.9 nmols/ml, respectively, p = 0.0001). Insulin resistance was independently associated with ox-LDL (p = 0.01) and TBARS levels (p = 0.01). We found no differences in the intake of various macro- and micronutrients between the two groups and there was no association between nutrient intake and ox-LDL or TBARS. CONCLUSION: Subjects with NASH have significantly higher systemic levels of lipid peroxidation products and this could indicate an increased risk of cardiovascular disease. More studies are needed to evaluate this possibility.

UR - http://www.scopus.com/inward/record.url?scp=4444382031&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=4444382031&partnerID=8YFLogxK

U2 - 10.1111/j.1572-0241.2004.30159.x

DO - 10.1111/j.1572-0241.2004.30159.x

M3 - Article

VL - 99

SP - 1497

EP - 1502

JO - American Journal of Gastroenterology

JF - American Journal of Gastroenterology

SN - 0002-9270

IS - 8

ER -